NICE has endorsed DERM, an autonomous AI medical device developed by Skin Analytics, for detecting skin cancer. This recognition marks a major step in using AI to free up clinician capacity and improve patient outcomes across the NHS.
NICE reviewed various technologies and recommended DERM as the only AI tool suitable for NHS use. It is the first dermatology solution to achieve a class III CE marking under the European Medical Device Regulation and a positive recommendation from NICE’s Early Value Assessment programme.
Dr Julia Schofield, Consultant Dermatologist, said: “The NHS is in crisis. This tool, approved as safe by regulators, has the potential to reassure patients and avoid the necessity for hospital visits.”
